Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

36.75 -0.04 (-0.11%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Twist Bioscience Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >
Earnings Scheduled For February 2, 2024
Companies Reporting Before The Bell • W.W. Grainger (NYSE:GWW) is likely to report quarterly earnings at $8.05 per share on revenue of $4.04 billion. 
Via Benzinga
Twist Bioscience Earnings Preview
Via Benzinga
Twist Bioscience Corp Daily Investment Opportunity
Twist Bioscience is a public biotechnology company founded in 2013 and it’s based in South San Francisco. It manufactures synthetic DNA and DNA products for customers in a wide range of industries. 
Via Talk Markets
Goldman Sachs Upgrades Twist Bioscience, Says Express Genes Launch Will Drive Margin Expansion
Goldman Sachs upgrades Twist Bioscience as Express Genes launch addresses SynBio division's gross margin issues. With 5-7 days gene delivery, TWST taps into a previously inaccessible market, enhancing... 
Via Benzinga
Twist Bioscience: Q4 Earnings Insights
Via Benzinga
Why Shares of Twist Bioscience Are Up Friday
The company reported improved financials in the third quarter. 
Via The Motley Fool
Twist Bioscience Stock Soars After Q3 Report - Here's Why
Twist Bioscience Corp (NASDAQ: TWST) reported Q3 sales increased 14% Y/Y to $63.7 million, beating the consensus of $60.71 million. 
Via Benzinga
Twist Bioscience's Earnings Outlook
Via Benzinga
Netflix To Rally Over 13%? Here Are 10 Top Analyst Forecasts For Wednesday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Biotech Playbook: Small Caps Show Momentum Peaking During
The momentum of selected stocks was strong up until early January was encouraging but we need less volatility in period ahead to conform a new bull market. 
Via Talk Markets
3 Genomics Stocks to Unlock the Future of Medicine
Genomics stocks stand to surge in 2024 after the FDA approved the nation's first gene-editing therapeutic for clinical use. 
Via InvestorPlace
Tuesday Talk: CPI Data And FOMC Meeting Hold Back Market Breakout
While the market continues towards making new highs, it is falling short of making a breakout rally. Forthcoming CPI data and the upcoming FOMC meeting may be the catalyst for same. 
Via Talk Markets
Biotech Is Coming Back, Can The Run Last?
The rally can be attributed to lower interest rates and seasonal factors from the end of Q4 through January. But recently some major biopharmaceutical deals have supported the rally. 
Via Talk Markets
Five Best Performing Stocks Of The Top ETF Of November
Most stocks in ARKK’s portfolio delivered strong returns in November. These five led the way. 
Via Talk Markets
Topics ETFs
Cramer Says No To This EV Maker, But Recommends This Major Automaker Stock: It 'Goes Up And Up'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said no to Lucid Group, Inc. 
Via Benzinga
S&P 500 Edges Higher; Buckle Shares Surge After Q3 Earnings
U.S. stocks traded slightly higher toward the end of trading, with the Nasdaq Composite gaining around 30 points on Friday. The Dow traded up 0.07% to 34,969.63 while the NASDAQ rose 0.21% to... 
Via Benzinga
Topics Stocks
Why Dolby Laboratories Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Dolby Laboratories, Inc. (NYSE: DLB) fell during Friday’s session following weak guidance. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Crude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales
U.S. stocks traded mostly flat midway through trading on Friday. The Dow traded up 0.01% to 34,945.78 while the NASDAQ fell 0.03% to 14,109.53. The S&P 500 also rose, gaining, 0.05% to 4,510.71. 
Via Benzinga
Topics Stocks
Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday
U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday. 
Via Benzinga
Topics Stocks
DNA-Maker Twist Bioscience Catapults 21% As 'Solid' Outlook That Tops Its Peers
The company expects sales to grow 16% to 18% in fiscal year 2024, which is already underway. 
Via Investor's Business Daily
Why Synthetic DNA Company Twist Bioscience Shares Are Jumping Today
Twist Bioscience Corp's (NASDAQ: TWST) Q4 sales increased 16.8% Y/Y to $66.9 million,  
Via Benzinga
Biden Administration Restarts Distribution Of Free At Home COVID-19 Tests, After Suspending For Year
In response to the escalating spread of the virus nationwide, the Biden administration declared that it would recommence offering free at-home COVID tests to American households starting next Monday. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 27, 2023
Via Benzinga
Biotech Bonanza: 3 Top DNA Stocks With Revolutionary Potential
DNA powers almost all biotechnology applications today. These leading DNA stocks are ready to reap the rewards of a growing industry. 
Via InvestorPlace
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For August 4, 2023
Companies Reporting Before The Bell • WPP (NYSE:WPP) is projected to report earnings for its first quarter. • Anglogold Ashanti (NYSE:AU) is likely to report earnings for its first quarter. 
Via Benzinga
2 Cathie Wood Growth Stocks That Could Make You Richer
These two biotechs could be winning plays for aggressive investors. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.